MYCOLOGY 2020 will now be MYCOLOGY 2021 and will take place on 11th & 12th June 2021
2-day virtual conference
Register nowMycology 2020 Steering Committee Chairs:
Dr. S. G. Agrawal, BSc, FRCP, FRCPath, PhD
Senior Lecturer and Honorary Consultant, Barts Health NHS Trust & Blizard Institute, Queen Mary University of London
Professor Neil A.R Gow FRS, FMedSci, FRSE, FRSB, FAAM
Deputy Vice-Chancellor for Research and Impact and Professor of Microbiology at University of Exeter
Organising Committee: Dr. Samir Agrawal, Prof. Neil Gow, Prof. Elaine Bignell, Dr. Mansour Ceesay, Dr. Jonathan Lambourne, Dr. Rohini Manuel, Prof. Malcolm Richardson, Prof. Paul Verweij, Prof. Adilia Warris, Dr. Lewis White, Dr. Mansour Ceesay, Dr. Darius Armstong-James, Dr Rebecca Gorton, Dr. Paul Pfeffer and Dr. Duncan Wilson
The webinar “Aspergillosis and COVID-19: lessons learned in diagnosis and treatment” from Fungal Update and British Society for Medical Mycology was held on December 11th, 2020. You can still access the full recording of the webinar by registering below.
Posters and authors will be present at the meeting in June.
Programme
Welcome and opening remarks
Host susceptibility to pathogenic fungi
Cologne, Germany
Turin, Italy
London
Q&A
Who regulates the regulator? – Kinase mediated regulation of the molecular chaperone Hsp90 and its role in fungal virulence
Mitochondrial reactive oxygen species regulate macrophage antifungal responses.
Comparative genomic analyses of A. fumigatus strains reveals disease-specific pathogenicity drivers
Q&A
Haemato-Oncology 2: Is there an optimal IFD protocol?
Cryptococcus as a model system for gene expression regulation: control of protein abundance and structure by alternate start codons and their sequence context
Gilead Fellows Talk 1: Antifungal modes of action: Old and New
Introduction from the chair
Incidence and pathogenesis of invasive aspergillosis in intensive care patients with severe influenza (AspiFlu)
The impact of COVID-19 on treating fungal disease in the ICU: A case study
Live Q&A
Lunch break
COVID-19 and invasive aspergillosis: what do we need to know?
A Clinical Perspective on the Management of CAPA
Q&A
Medical mycology at a cross-road: the role of international organizations
Performance of different lateral flow assays for rapid detection of aspergillosis – Presentation via Skype
Assays for rapid detection of antifungal resistance
Next-generation sequencing for invasive fungal diseases: Applications in a clinical mycology laboratory
Q&A
Pneumocystis jirovecii, from the organism to the disease
Long-distance Immune Control by Cryptococci
COFUN: An update on the construction and use of genome wide-knockout library in A. fumigatus
Q&A
Fungal adaptation in CF and CPA through parasex: How to survive without sex.
An evaluation of the performance of the IMMY sona Aspergillus Galactomannan Lateral flow assay when testing serum to aid in the diagnosis of invasive aspergillosis.
Identification Of Drug Combinations To Entrap In A Carrier For The Treatment Of Onychomycosis
Carbohydrate metabolism regulates immune responses of the oral epithelium to Candida albicans
Case Study 1- A stroke of bad luck
Case Study 2-
Close of day 1
Microbiome-mycobiome interactions and human disease
Understanding the impact of genetic variation on the host response towards infection – Presentation via Skype
Gilead Fellows Talk 2 : Triazole resistance mechanisms in Aspergillus fumigatus: what do we learn from full genome sequencing?”
Q&A
Interdependency of host and pathogen protein persulfidation governs disease severity in experimental and human aspergilloses
Toward new insights into the role of the lung microbiota in invasive pulmonary aspergillosis
Epithelial uptake of Aspergillus fumigatus spores drives efficient fungal clearance in vivo and is aberrant in Chronic Obstructive Pulmonary Disease (COPD) patients
Q&A
C-type lectins in anti-fungal immunity
Diagnosis of fungal pathogens in CF
Sensitization in Non-Cystic Fibrosis Bronchiectasis
Managing non-Aspergillus mould infections
Q&A
Optimal fungal management – Immunology not microbiology?
Session sponsored by IMMY
The turning point of rapid tests for the diagnosis of invasive fungal infections
Session sponsored by Cidara Therapeutics
Rezafungin: a Novel, Once-Weekly Echinocandin in Phase 3 Development for Treatment and Prevention of Invasive Fungal Disease.
Lunch break
Update on influenza associated aspergillosis
SNPs and risk stratification for the clinic
Host response to Aspergillus in asthma and allergic lung disease
Offered paper – Aspergillus fumigatus Cell Wall Promotes Apical Airway Epithelial Recruitment of Human Neutrophils
Q&A
Reverse engineering of Aspergillus pH signalling for anti-fungal drug discovery
Calcium sequestration by fungal melanin reprograms macrophage metabolism toward glycolysis and antifungal immunity
Prospective evaluation of T2MR for the diagnosis of Invasive Candidiasis in ICU patients
Q&A
Plenary : Presentations of prizes for winning posters
Closing remarks
Abstract Submission has reopened for submission
Thank you for your entries – the committee has commented on the high quality of submissions.
Please note that all accepted abstracts will be published in the Frontiers in Cellular and Infection Microbiology supplement
As the event has now been postponed until June 2021, abstract submission has re-opened. All successful oral and poster submissions will roll forward to June but there is an opportunity for new abstracts to be submitted. The closing deadline for poster submissions, is now 23rd April 2021. Please use the template provided and submit to hayley@pagemedical.co.uk
If there are any queries relating to abstract submission please contact Hayley Brown at Page Medical on 01353 780060
Sponsors and Exhibitors
This event is sponsored in part by pharmaceutical companies.
We thank all of our sponsors for their continued support of Mycology 2021.
Registration
Registration options and rates are below.
The fees below include registration for both days of the virtual Mycology 2021 conference.
Previously purchased registrations will automatically be transferred to the virtual conference and further details will be sent closer to the time. The delegate passes for the virtual conference have been reduced and so you will receive a partial refund.
£100
Standard registration
£90
Standard BSMM & / or ISHAM member
£45
Student BSMM & / or ISHAM member
£50
Trainee
£250
Commercial
conferences, conventions, exhibitions, awards dinners and corporate events
events and exhibition space in central London